Glow Lifetech Grants Stock Options
Glow Lifetech Grants Stock Options
Toronto, Ontario--(Newsfile Corp. - December 27, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has granted 3,650,000 stock options (the "Options") to various officers and consultants of the Company. Each Option is exercisable at a price of $0.06 for one common share of the Company (each a "Common Share") for a period of five years from the date of grant and are being issued under the terms of the Company's Omnibus Long-Term Incentive Plan. The Options, and any Common Shares issued upon exercise of the Options, are subject to a four-month and one day resale restriction from the date of grant.
多倫多,安大略省--(資訊公司 - 2024年12月27日)- Glow Lifetech CORP.(CSE: GLOW)(場外交易粉色: GLWLF)(FSE: 9DO)("Glow"或"公司")欣然宣佈,已向公司各個高管和顧問授予3,650,000個股票期權("期權")。每個期權可在授予之日起五年內以$0.06的價格購買一股公司普通股(每股稱爲"普通股"),並根據公司的綜合長期激勵計劃的條款進行發行。期權及因行使期權而發行的任何普通股,自授予之日起,均受四個月零一天的轉售限制。
The aforementioned grant of Options resulted in certain insiders of the Company receiving an aggregate of 2,500,000 Stock Options. The Company has relied on the exemptions from the valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"), contained in section 5.5(b) and 5.7(a) of MI 61-101 in respect of such insider participation.
上述期權授予導致公司某些內部人士共獲得2,500,000個股票期權。公司依賴於多項式文書61-101 - 特殊交易中保護少數安防持有人的評估和少數股東批准要求的豁免,具體見MI 61-101第5.5(b)和5.7(a)節關於此類內部人士參與的相關條款。
SUBSCRIBE: For more information on Glow or to subscribe to the Company's mail list visit:
訂閱:有關Glow的更多信息或訂閱公司的郵件列表,請訪問:
About Glow Lifetech Corp
關於Glow Lifetech CORP
Glow Lifetech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption and effectiveness. Glow has a groundbreaking, plant-based MyCell Technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds.
Glow Lifetech是一家總部位於加拿大的生物技術公司,專注於生產具有顯著增強的生物利用度、吸收性和效果的營養保健品和基於大麻素的產品。Glow擁有突破性的植物基MyCell技術傳遞系統,能夠將吸收性差的天然化合物轉變爲增強的水溶性濃縮液,從而釋放這些有價值化合物的全部治療潛力。
Website:
網站:
Contact:
James Van Staveren
Glow Lifetech Corp.
TF. 855-442-GLOW (4569)
ir@glowlifetech.com
聯繫:
詹姆斯·範·斯塔弗倫
Glow Lifetech CORP.
TF. 855-442-GLOW (4569)
ir@glowlifetech.com
Forward-looking Information Cautionary Statement
前瞻性信息注意事項
Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. There are uncertainties inherent in forward-looking information, including factors beyond the Company's control. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company's filings with Canadian securities regulators, which filings are available at
除了歷史事實的陳述外,本新聞稿包含某些符合適用證券法意義的「前瞻性信息」。前瞻性信息通常以「計劃」、「期望」、「預測」、「打算」、「相信」、「預期」、「估計」等詞語或某些事件或條件「可能」或「將」發生的陳述爲特徵。前瞻性陳述是基於作出陳述時的意見和估計,並受到各種風險和不確定性以及其他可能導致實際事件或結果與前瞻性陳述中預期的結果有重大差異的因素的影響。前瞻性信息固有的不確定性,包括超出公司控制範圍的因素。除法律要求外,公司沒有義務更新前瞻性信息,如果情況或管理層的估計或意見發生變化。請讀者謹慎對待前瞻性陳述,不要過度依賴。關於可能影響財務結果的風險和不確定性的更多信息已包含在公司向加拿大證券監管機構提交的文件中,這些文件可在
譯文內容由第三人軟體翻譯。